# Adaptive and Behavioral Phenotype in Pediatric 22q11.2 Deletion Syndrome: Characterizing a High-Risk Neurogenetic Copy Number Variant

**Authors:** Larissa Salustiano Evangelista Pimenta, Claudia Berlim de Mello, Guilherme V. Polanczyk, Leslie Domenici Kulikowski, Maria Isabel Melaragno, Chong Ae Kim

PMC · DOI: 10.3390/genes17020120 · Genes · 2026-01-24

## TL;DR

This study explores how children with a specific genetic deletion face challenges in adaptive functioning and behavior, highlighting the need for early intervention.

## Contribution

The study characterizes adaptive and behavioral profiles in pediatric 22q11.2 deletion syndrome, emphasizing adaptive functioning as a key outcome for early evaluation.

## Key findings

- Intellectual disability is highly prevalent in children with 22q11.2DS.
- Adaptive functioning is compromised across domains, with socialization scores relatively higher than daily living skills.
- Sociodemographic factors and social problems are linked to behavioral difficulties and lower adaptive functioning.

## Abstract

22q11.2 deletion syndrome (22q11.2DS) is the most common recurrent microdeletion in humans and a prototypical high-risk neurogenetic copy number variant (CNV) associated with a broad spectrum of neurodevelopmental and psychiatric disorders, including intellectual disability (ID), autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), anxiety, and psychotic symptoms. This hemizygous deletion encompasses multiple genes involved in brain development and neural circuit function, contributing to marked phenotypic variability and multisystem involvement. In pediatric populations, deficits in adaptive functioning are frequently reported and may occur independently of global intellectual impairment, reflecting broader behavioral vulnerabilities within this genetic risk architecture. Background/Objectives: This study aimed to characterize the sociodemographic, clinical, and intellectual profiles of children and adolescents with 22q11.2DS and to examine adaptive functioning and its associations with behavioral difficulties. Methods: Thirty-four patients aged 1–17 years with a confirmed molecular diagnosis of 22q11.2DS were assessed. Standardized instruments were used to evaluate cognitive performance, adaptive functioning, and behavioral outcomes. Results: Intellectual disability was highly prevalent, with most participants showing combined cognitive and adaptive impairments. Adaptive functioning was compromised across domains, with relatively higher socialization scores compared to other areas, such as daily living skills. Multivariate analyses indicated associations between sociodemographic factors and behavioral difficulties, as well as between social problems and lower global adaptive functioning. Conclusions: Together, these findings contribute to the characterization of the adaptive and behavioral phenotype associated with a high-risk neurogenetic CNV and highlight the relevance of adaptive functioning as a key outcome for early evaluation and intervention in pediatric 22q11.2DS.

## Linked entities

- **Diseases:** intellectual disability (MONDO:0001071), autism spectrum disorder (MONDO:0005258), attention-deficit/hyperactivity disorder (MONDO:0007743), anxiety (MONDO:0005618)

## Full-text entities

- **Diseases:** Behavioral difficulties (MESH:D001523), impairments in peer relationships (MESH:D060825), cyanosis (MESH:D003490), weaknesses in literacy acquisition (MESH:D018908), Disruptive behavior disorders (MESH:D019958), anxiety (MESH:D001007), oligohydramnios (MESH:D016104), cardiorespiratory complications (MESH:D008107), gastroesophageal reflux (MESH:D005764), injury to (MESH:D014947), intrauterine growth restriction (MESH:D005317), ASD (MESH:D000067877), tetralogy of Fallot (MESH:D013771), congenital cardiac and palatal malformations (MESH:C535853), neurological abnormalities (MESH:D009461), ventricular septal defect (MESH:D006345), deficits in nonverbal intellectual abilities (MESH:C000726807), respiratory distress (MESH:D012128), anxiety disorder (MESH:D001008), difficulties in (MESH:D051346), mood instability (MESH:D019964), high-arched palate (MESH:D007569), learning delays (MESH:D007859), intellectual functioning (MESH:C565406), microcephaly (MESH:D008831), hypertelorism (MESH:D006972), infections (MESH:D007239), 22q11.2 Deletion Syndrome (MESH:D004062), psychomotor agitation (MESH:D011595), psychotic (MESH:D011618), ADHD (MESH:D001289), COVID-19 (MESH:D000086382), genetic lesion (MESH:D020022), immunological and autoimmune dysfunctions (MESH:D007154), neuropsychiatric (MESH:C000631768), tachypnea (MESH:D059246), Congenital heart defects (MESH:D006330), hypocalcemia (MESH:D006996), withdrawal (MESH:D013375), epilepsy (MESH:D004827), interruption of the aortic arch (MESH:C566271), maternal hypertension (MESH:D006973), ID (MESH:D008607), encephalopathy (MESH:D001927), Major malformations (MESH:D004830), Problems (MESH:D019973), Delays in neuropsychomotor development (MESH:D002658), CNV (MESH:D008881), internalizing and externalizing behavioral problems (MESH:D000082122), CBCL (MESH:D002653), cognitive and adaptive impairments (MESH:D003072), Deficits in adaptive functioning (MESH:D018489), long face (MESH:D000094024), social anxiety disorder (MESH:D000072861), phobias (MESH:D010698), social (OMIM:300082), endocrine, genitourinary, gastrointestinal, and neurological abnormalities (MESH:D014564), Depressed (MESH:D003866), Aggressive Beha (MESH:D010554)
- **Chemicals:** clonazepam (MESH:D002998), risperidone (MESH:D018967), fluoxetine (MESH:D005473), chlorpromazine (MESH:D002746)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12941017/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC12941017/full.md

---
Source: https://tomesphere.com/paper/PMC12941017